Division of Movement Disorders

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Huntington Disease 28%
3. Dystonia 26%
4. Positron-Emission Tomography 24%
5. Parkinsonian Disorders 23%
6. Brain 23%
7. Synucleins 21%
8. Deep Brain Stimulation 20%
9. Manganese 18%
10. Levodopa 17%
11. Primates 17%
12. Dystonic Disorders 16%
13. Corpus Striatum 16%
14. Dopamine 15%
15. Torticollis 15%
16. Subthalamic Nucleus 14%
17. Tremor 14%
18. Vesicular Acetylcholine Transport Proteins 10%
19. Mental Status and Dementia Tests 10%
20. Gait 10%
21. Genes 10%
22. Cerebrovascular Circulation 9%
23. Mutation 9%
24. Neurons 9%
25. Movement Disorders 9%
26. Macaca 9%
27. Putamen 9%
28. Regional Blood Flow 8%
29. Alzheimer Disease 8%
30. Type A Botulinum Toxins 7%
31. N-methylbenperidol 7%
32. Haplorhini 7%
33. Papio 7%
34. Basal Ganglia 7%
35. Amyloid 7%
36. Neurodegenerative Diseases 7%
37. Dopamine D2 Receptors 7%
38. Dementia 7%
39. Welding 7%
40. Cerebellum 7%
41. Essential Tremor 7%
42. Substantia Nigra 6%
43. Learning 6%
44. Blepharospasm 6%
45. Dopamine D3 Receptors 6%
46. Medicare 6%
47. Magnetic Resonance Imaging 6%
48. Neuroimaging 6%
49. Therapeutics 6%
50. Lewy Bodies 6%
51. Dyskinesias 6%
52. Saccades 5%
53. Quality of Life 5%
54. Injections 5%
55. Age of Onset 5%
56. Occupational Groups 5%
57. alpha-Synuclein 5%
58. In Vitro Techniques 5%
59. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 5%
60. Ligands 5%
61. Confidence Intervals 5%
62. Phenotype 5%
63. Globus Pallidus 5%
64. Placebos 5%